Multiple Myeloma
News
Erythema extent predicts death in cutaneous GVHD
Study: Extent of skin erythema correlates with deaths from graft-versus-host disease in blood cancer patients after stem cell transplants.
News
Multiple myeloma diagnosed more via emergency care during COVID
While trying to avoid COVID-19 infection, patients ultimately diagnosed with multiple myeloma may have delayed interactions with healthcare...
News
Blenrep for multiple myeloma withdrawn from U.S. market
As requested by the U.S. Food and Drug Administration, the multiple myeloma drug blenrep is being taken off the market after disappointing results...
News
CAR T-cell therapy neurotoxicity linked to NfL elevations
Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
Original Research
Agent Orange Exposure, Transformation From MGUS to Multiple Myeloma, and Outcomes in Veterans
This study explored variation in survival related to Agent Orange exposure, transformation from MGUS to multiple myeloma, and survival as a...
News
Fewer transplants for MM with quadruplet therapy?
Findings bode well for quadruple drug therapy in treating newly diagnosed multiple myeloma.
Case Reports
Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma
In patients with multiple myeloma, thrombotic microangiopathy is a rare adverse event associated with proteasome inhibitors, such as bortezomib,...
Conference Coverage
‘Extremely exciting’ study results guide MM treatment options
New trial data help inform the tailoring of effective treatment approaches for patients with newly diagnosed multiple myeloma (MM).
News
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
News
Obesity increasing the risk for cancer: It’s complicated
For some cancers it was “very clear that obesity increased the risk ... but for some other cancer types, we either don’t have enough data yet or...